Table 1.
Clinical characteristics.
| Variables | LT (n = 18) | NT (n = 28) | p-value |
|---|---|---|---|
| Age (yr) | 42.22 ± 8.10 | 41.36 ± 6.85 | 0.68 |
| BMI (kg/m2) | 26.56 ± 5.12 | 25.72 ± 3.93 | 0.67 |
| SBP (mmHg) | 129.78 ± 5.07 | 127.36 ± 3.33 | 0.37 |
| DBP (mmHg) | 89.72 ± 3.54 | 84.39 ± 2.03 | 0.16 |
| Biochemical parameters | |||
| FSH (mIU/mL) | 5.98 ± 3.19 | 5.83 ± 2.72 | 0.88 |
| LH (mIU/mL) | 5.43 ± 2.23 | 5.98 ± 2.82 | 0.47 |
| PRL (ng/mL) | 12.89 ± 9.63 | 13.61 ± 4.48 | 0.77 |
| LDL-C (mmol/L) | 3.13 ± 1.24 | 3.31 ± 0.79 | 0.59 |
| TG (mmol/L) | 2.18 (1.45, 5.07) | 1.66 (1.07, 2.45) | 0.12 |
| TC (mmol/L) | 5.14 ± 1.91 | 5.11 ± 1.13 | 0.95 |
| URIC (μmol/L) | 392.72 ± 111.31 | 348.39 ± 69.52 | 0.14 |
| FPG (mmol/L) | 10.52 ± 3.08 | 9.06 ± 3.08 | 0.13 |
| HbA1c (%) | 9.25 ± 1.97 | 9.70 ± 2.52 | 0.50 |
| INS (μU/mL) | 10.98 ± 6.64 | 7.56 ± 5.14 | 0.08 |
| C-P (ng/mL) | 2.76 ± 1.16 | 1.79 ± 0.84 | 0.002 |
| CRP (mg/L) | 1.83 (0.67, 3.25) | 1.16 (0.79, 1.71) | 0.29 |
| Duration of diabetes (yr, n [%]) | |||
| 0–5 | 13 (72.2%) | 18 (64.3%) | 0.75 |
| >5 | 5 (27.8%) | 10 (35.7%) | |
| Medical history (n [%]) | |||
| Hypertension | 10 (55.6%) | 6 (21.4%) | 0.03 |
| Coronary artery disease | 2 (11.1%) | 2 (7.1%) | 0.64 |
| Fatty liver | 15 (83.3%) | 20 (71.4%) | 0.29 |
| Smoking history (n [%]) | |||
| None | 4 (22.2%) | 7 (25%) | 0.96 |
| Past | 3 (16.7%) | 4 (14.3%) | |
| Current | 11 (61.1%) | 17 (60.7%) | |
| Alcohol history (n [%]) | |||
| None | 8 (44.4%) | 8 (28.6%) | 0.52 |
| Social | 7 (38.9%) | 15 (53.6%) | |
| More than twice a week | 3 (16.7%) | 5 (19.8%) | |
| Medication history (n [%]) | |||
| Acarbose | 1 (5.6%) | 3 (10.7%) | 0.83 |
| Metformin | 3 (16.7%) | 6 (21.4%) | |
| Linagliptin | 3 (16.7%) | 1 (3.6%) | |
| Acarbose+ metformin | 2 (11.1%) | 4 (14.3%) | |
| Metformin + linagliptin | 1 (5.6%) | 2 (7.1%) | |
| None | 8 (44.4%) | 12 (42.9%) |
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; CAD, coronary artery disease; FPG, fasting blood glucose; INS, insulin; HbA1c, glycosylated hemoglobin A1c; URIC, uric acid; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride.
All data except TG were normal distribution and were analyzed by t-test, expressed as mean ± SD. TG of non-normal distribution were analyzed by non-parametric Wilcoxon test and expressed as median with interquartile range (IQR). Fisher exact tests were used to compare the constituent ratio.